Stocks and Investing Stocks and Investing
Wed, August 7, 2024
[ 12:00 AM ] - United States, WOPRAI
Jamie Cook Reiterated (CAT) at Strong Buy with Increased Target to $399 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Steven Fisher Maintained (CAT) at Strong Sell with Increased Target to $285 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Adam Seiden Maintained (CAT) at Hold with Increased Target to $335 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Feniger Maintained (CAT) at Strong Buy with Decreased Target to $376 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Bernie McTernan Reiterated (CART) at Hold on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (CART) at Buy with Increased Target to $50 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Brian Pitz Maintained (CART) at Hold with Increased Target to $39 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Scott Devitt Maintained (CART) at Hold with Increased Target to $38 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Mark Zgutowicz Reiterated (CART) at Hold on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Zekauskas Maintained (CBT) at Hold with Increased Target to $105 on, Aug 7th, 2024
[ 12:00 AM ] - United States, WOPRAI
Ryan Brinkman Maintained (CAR) at Buy with Decreased Target to $175 on, Aug 7th, 2024
Tue, August 6, 2024
[ 12:00 AM ] - United States, WOPRAI
Sebastiano Petti Maintained (CABO) at Hold with Increased Target to $480 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
John Ivankoe Maintained (CAKE) at Sell with Decreased Target to $38 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Jim Kelleher Downgraded (CBRL) to Hold on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Leithead Maintained (CC) at Hold with Decreased Target to $22 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
John McNulty Maintained (CC) at Buy with Decreased Target to $30 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Joshua Spector Maintained (CC) at Strong Buy with Decreased Target to $28 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Zekauskas Maintained (CC) at Hold with Decreased Target to $18 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Joshua Spector Maintained (CBT) at Hold with Decreased Target to $98 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Yaron Werber Maintained (BNTX) at Hold with Decreased Target to $85 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Cory Kasimov Maintained (BMRN) at Buy with Increased Target to $115 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Gena Wang Maintained (BMRN) at Buy with Decreased Target to $110 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Luca Issi Reiterated (BMRN) at Hold and Held Target at $100 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Paul Matteis Maintained (BMRN) at Strong Buy with Increased Target to $112 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
George Farmer Maintained (BMRN) at Hold with Increased Target to $86 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Phil Nadeau Maintained (BMRN) at Strong Buy with Decreased Target to $120 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Reiterated (BCRX) at Strong Buy and Held Target at $30 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Brian Abrahams Reiterated (BCRX) at Buy and Held Target at $10 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Gena Wang Maintained (BCRX) at Hold with Increased Target to $7 on, Aug 6th, 2024
[ 12:00 AM ] - United States, WOPRAI
Jonathan Wolleben Maintained (BCRX) at Buy with Increased Target to $16 on, Aug 6th, 2024

Jonathan Wolleben Maintained (BCRX) at Buy with Increased Target to $16 on, Aug 6th, 2024


Published on 2024-10-28 13:16:18 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy with Increased Target from $15 to $16 on, Aug 6th, 2024.

Jonathan has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan

  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, May 7th, 2024

Contributing Sources